Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion
NASDAQ:SSKN

Strata Skin Sciences Earnings Date & Estimates

Strata Skin Sciences logo
$0.0002 +0.00 (+100.00%)
As of 10/21/2026 01:16 PM Eastern

Strata Skin Sciences is estimated to report earnings on Tuesday, November 17, 2026.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Announcement Date
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Strata Skin Sciences

Strata Skin Sciences is expected to post earnings of -$0.38 per share on revenue of $5.41 million. In the same quarter a year earlier Strata Skin Sciences reported -$0.36 per share on revenue of $6.93 million. Strata Skin Sciences last reported on November 13, 2025, posting -$0.36 per share and missing the -$0.24 consensus estimate. Strata Skin Sciences has beaten the consensus EPS estimate in 1 of its last 5 quarters.

Consensus Estimates

Consensus EPS
-$0.38
Expected Revenue
$5.41 million
Prior-Year EPS
-$0.36
Prior-Year Revenue
$6.93 million
Expected Revenue Growth
-21.9%

Recent Track Record

Last Reported
Q3 2025
Last Quarter EPS
-$0.36 (Missed by -$0.12)
Last Quarter Revenue
$6.93 million
EPS Beat Rate
1 of last 5 quarters

Prepare for the Earnings Call

Strata Skin Sciences Earnings FAQ

Strata Skin Sciences (NASDAQ:SSKN) is estimated to report earnings on Tuesday, November 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Strata Skin Sciences to post earnings of -$0.38 per share for the quarter.

The consensus revenue estimate for Strata Skin Sciences is $5.41 million for the quarter.

Strata Skin Sciences Earnings Headlines

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334372/23161/en/strata-skin-sciences-appoints-medical-device-commercial-leader-erica-jordan-as-chief-executive-officer.html
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
May 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/18/3296628/23161/en/new-peer-reviewed-publication-confirms-unprecedented-response-rates-for-strata-s-excimer-laser-combined-with-jak-inhibitors-in-pediatric-vitiligo.html
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
 |  Banyan Hill Publishing (Ad)
STRATA Skin Sciences Confirms Nasdaq Delisting
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3241523/23161/en/strata-skin-sciences-confirms-nasdaq-delisting.html
STRATA cites study supporting 308 nm laser for psoriasis
February 18, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/strata-cites-study-supporting-308-nm-laser-for-psoriasis/ar-AA1WzU47
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
February 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/18/3240190/23161/en/johns-hopkins-dermatology-expands-advanced-care-for-inflammatory-and-autoimmune-skin-conditions-with-addition-of-xtrac-excimer-laser.html
See More Strata Skin Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Strata Skin Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Strata Skin Sciences and other key companies, straight to your email.

About Strata Skin Sciences

Strata Skin Sciences (NASDAQ:SSKN) is a medical technology company focused on developing and commercializing products for dermatology and aesthetic medicine. Its solutions are designed to address conditions such as psoriasis, vitiligo, acne and other skin disorders, serving dermatology practices, physicians and patients.

The company’s product portfolio includes the XTRAC excimer laser system, which delivers targeted ultraviolet light therapy for psoriasis, vitiligo and related conditions. Strata also offers the VTRAC excimer laser system and TheraClearX, a device-based acne treatment that combines light therapy with vacuum technology. Products are marketed primarily through dermatology providers in the United States, with international distribution in selected markets.

Strata Skin Sciences traces its corporate history to Mela Sciences and adopted its current name after expanding its focus on dermatology technologies, including assets acquired from PhotoMedex. The company is headquartered in Horsham, Pennsylvania, and commercializes its products through a combination of direct sales and distribution relationships.

View Strata Skin Sciences Profile
Earnings Tools